The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia
Open accessAbstract
Background: No controlled trial of treatment of generalised social phobia has been conducted in general practice. Aims: To examine the efficacy of sertraline or exposure therapy, administered alone or in combination in this setting. Method: Study was of a randomised, double-blind design. Patients (n=387) received sertraline 50–150 mg or placebo for 24 weeks. Patients were additionally randomised to exposure therapy or general medical care. Results: Sertraline-treated patients were significantly more improved than non-sertraline-treated patients (χ 2=12.53,P<0.001; odds ratio=0.534; 95% CI 0.347–0.835). No significant difference was observed between exposure— and non-exposure-treated patients (χ 2=2.18,P=0.140; odds ratio=0.732; 95% CI 0.475–1.134). In the pairwise comparisons, combined sertraline and exposure (χ 2=12.32;P<0.001) and sertraline (χ 2=10.13;P=0.002) were significantly superior to placebo. Conclusions: Sertraline is an effective treatment for generalised social phobia. Combined treatment with sertraline and exposure therapy, conducted by the general practitioner, may enhance the treatment efficacy in primary care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Mattick, R. P., & Clarke, J. C. (1998) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(97)10031-6 · Cited by 3,367
Brief standard self-rating for phobic patients
Marks, I. M., & Mathews, A. M. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90041-x · Cited by 1,801
Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia: 12-Week Outcome
Heimberg, R. G., Liebowitz, M. R., Hope, D. A., Schneier, F. R., Holt, C. S., Welkowitz, L. A., Juster, H. R., Campeas, R., Bruch, M. A., Cloitre, M., et al. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1133 · Cited by 585
Phenelzine vs Atenolol in Social Phobia: A Placebo-Controlled Comparison
Liebowitz, M. R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., Fyer, A., Gorman, J., Papp, L., Davies, S., Gully, R., et al. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.49.4.290 · Cited by 444
Assessing impairment in patients with panic disorder: the Sheehan Disability Scale
Leon, A. C., Shear, M. K., Portera, L., & Klerman, G. L. (1992) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00788510 · Cited by 319
Social phobia in general health care: an unrecognised undertreated disabling disorder
Weiller, E., Bisserbe, J. C., Boyer, P., Lepine, J. P., & Lecrubier, Y. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.168.2.169 · Cited by 219
Research works printed but not linked: 19
- 10.1016/0165-0327(94)90118-X · DOI
- Stein, 1999, Fluvoxamine treatment of social phobia (social anxiety disorder): A double-blind, placebo-controlled study, American Journal of Psychiatry, 156, 756, 10.1176/ajp.156.5.756 · DOI · Paper page
- Sheehan, 1998, The Mini-International Neuropsychiatric Interview (MINI), the development and validation of a structured diagnostic psychiatric interview for DSM–IV and ICD–10, Journal of Clinical Psychiatry, 59, 22
- 1997, SAS/STAT Software: Changes and Enhancements through Release 6.12.
- O'Connor, 1999, Cognitive–behaviour therapy and medication in the treatment of obsessive–compulsive disorder: a controlled study, Canadian Journal of Psychiatry, 44, 64, 10.1177/070674379904400108 · DOI
- Lader, 1998, Interaction of pharmacological and psychological treatments of anxiety, British Journal of Psychiatry, 173, 42, 10.1192/S0007125000293513 · DOI
- 10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
- Haug, 2000, The treatment of social phobia in general practice: Is exposure therapy feasible?, Family Medicine, 17, 114
- Friis, 1987, Clinical Research in Psychiatry, 9
- Fawcett, 1987, Clinical management imipramine/placebo manual, Psychopharmacology Bulletin, 23, 309
- Davidson, 1991, The Brief Social Phobia Scale, Journal of Clinical Psychiatry, 52, 48
- 1994, Diagnostic and Statistical Manual of Mental Disorders
- 10.1037/h0027806 · DOI · Paper page
- Guy, 1976, ECDEU Assessment Manual for Psychopharmacology Revised.
- 10.1097/00004850-199606003-00011 · DOI
- 10.1192/bjp.175.2.120 · DOI · Paper page
- 10.1097/00004714-199312000-00008 · DOI · Paper page
- 10.1097/00004714-199812001-00002 · DOI
- 10.1097/00005650-199303000-00006 · DOI · Paper page
Cited by
Stein, M. B., & Stein, D. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60488-2 · Cited by 1,137
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
A Meta-Analytic Review of Adult Cognitive-Behavioral Treatment Outcome Across the Anxiety Disorders
Norton, P. J., & Price, E. C. (2007) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000253843.70149.9a · Cited by 612
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
Clark, D. M., Ehlers, A., McManus, F., Hackmann, A., Fennell, M., Campbell, H., Flower, T., Davenport, C., & Louis, B. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.6.1058 · Cited by 561
Cuijpers, P., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T., & Reynolds, C. F. (2013) · World Psychiatry · doi:10.1002/wps.20038 · Cited by 540
Stewart, R. E., & Chambless, D. L. (2009) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0016032 · Cited by 483
Enduring Effects for Cognitive Behavior Therapy in the Treatment of Depression and Anxiety
Hollon, S. D., Stewart, M. O., & Strunk, D. (2006) · Annual Review of Psychology · doi:10.1146/annurev.psych.57.102904.190044 · Cited by 466
The treatment of social anxiety disorder
Rodebaugh, T. L., Holaway, R. M., & Heimberg, R. G. (2004) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.07.007 · Cited by 424
Cuijpers, P., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T., & Reynolds, C. F. (2014) · World Psychiatry · doi:10.1002/wps.20089 · Cited by 424
Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia
Davidson, J. R. T., Foa, E. B., Huppert, J. D., Keefe, F. J., Franklin, M. E., Compton, J. S., Zhao, N., Connor, K. M., Lynch, T. R., & Gadde, K. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.1005 · Cited by 415
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
“Social anxiety disorder Follow-up study of (Blomhoff et al., 2001)”
BackgroundResultPsychological treatment of social anxiety disorder: a meta-analysis
Acarturk, C., Cuijpers, P., van Straten, A., & de Graaf, R. (2009) · Psychological Medicine · doi:10.1017/s0033291708003590 · Cited by 333
Social Anxiety Disorder: (532272011-001)
(2008) · PsycEXTRA Dataset · doi:10.1037/e532272011-001 · Cited by 258
Foa, E. B., Franklin, M. E., & Moser, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01552-4 · Cited by 219
“In light of the paucity of SP studies, we have included here a recent effectiveness study conducted by primary care physicians (Blomhoff et al 2001) despite methodologic limitations that would have precluded its inclusion (e.g., absence of blind assessors).”
BackgroundBlanco, C., Heimberg, R. G., Schneier, F. R., Fresco, D. M., Chen, H., Turk, C. L., Vermes, D., Erwin, B. A., Schmidt, A. B., Juster, H. R., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.11 · Cited by 206
Rief, W., Nestoriuc, Y., von Lilienfeld-Toal, A., Dogan, I., Schreiber, F., Hofmann, S. G., Barsky, A. J., & Avorn, J. (2009) · Drug Safety · doi:10.2165/11316580-000000000-00000 · Cited by 202
A Meta–Analytic Review of Psychological Treatments for Social Anxiety Disorder
Powers, M. B., Sigmarsson, S. R., & Emmelkamp, P. M. G. (2008) · International Journal of Cognitive Therapy · doi:10.1521/ijct.2008.1.2.94 · Cited by 191
Treatment of depression in children and adolescents
Ryan, N. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67321-7 · Cited by 176
Bandelow, B., Seidler-Brandler, U., Becker, A., Wedekind, D., & Rüther, E. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970601110273 · Cited by 166
Pharmacotherapy of anxiety disorders: A critical review
Koen, N., & Stein, D. J. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.4/nkoen · Cited by 151
Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial
Haug, T. T., Blomhoff, S., Hellstrøm, K., Holme, I., Humble, M., Madsbu, H. P., & Wold, J. E. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.4.312 · Cited by 151
Self-citationAnxiety disorders: a comprehensive review of pharmacotherapies
Hoffman, E. J., & Mathew, S. J. (2008) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20041 · Cited by 149
Ponniah, K., & Hollon, S. D. (2008) · Psychological Medicine · doi:10.1017/s0033291707000918 · Cited by 128
Hofmann, S. G., Smits, J. A. J., Rosenfield, D., Simon, N., Otto, M. W., Meuret, A. E., Marques, L., Fang, A., Tart, C., & Pollack, M. H. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12070974 · Cited by 121
Roshanaei-Moghaddam, B., Pauly, M. C., Atkins, D. C., Baldwin, S. A., Stein, M. B., & Roy-Byrne, P. (2011) · Depression and Anxiety · doi:10.1002/da.20829 · Cited by 102
Roest, A. M., de Jonge, P., Williams, C. D., de Vries, Y. A., Schoevers, R. A., & Turner, E. H. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.15 · Cited by 101
The evidence-based pharmacotherapy of social anxiety disorder
Blanco, C., Bragdon, L. B., Schneier, F. R., & Liebowitz, M. R. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000119 · Cited by 99
Wong, J., Gordon, E. A., & Heimberg, R. G. (2012) · Handbook of Evidence-Based Practice in Clinical Psychology · doi:10.1002/9781118156391.ebcp002027 · Cited by 96
Pharmacotherapy for social anxiety disorder (SAnD)
Williams, T., Hattingh, C. J., Kariuki, C. M., Tromp, S. A., van Balkom, A. J., Ipser, J. C., & Stein, D. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001206.pub3 · Cited by 84
Evidence-based pharmacotherapy for personality disorders
Ripoll, L. H., Triebwasser, J., & Siever, L. J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000071 · Cited by 83
Pharmacotherapy of social phobia
Davidson, J. R. T. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s417.7.x · Cited by 69
Psychological Treatments for Social Phobia
Rowa, K., & Antony, M. M. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505000603 · Cited by 65
Marom, S., Gilboa-Schechtman, E., Aderka, I. M., Weizman, A., & Hermesh, H. (2009) · Depression and Anxiety · doi:10.1002/da.20390 · Cited by 55
Cognitive-behavioral therapy for social anxiety disorder: the state of the science
Gordon, D., Wong, J., & Heimberg, R. G. (2014) · The Wiley Blackwell Handbook of Social Anxiety Disorder · doi:10.1002/9781118653920.ch22 · Cited by 50
Curtiss, J., Andrews, L., Davis, M., Smits, J., & Hofmann, S. G. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1285907 · Cited by 46
Gingnell, M., Frick, A., Engman, J., Alaie, I., Björkstrand, J., Faria, V., Carlbring, P., Andersson, G., Reis, M., Larsson, E.-M., et al. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.175794 · Cited by 44
Shepardson, R. L., Buchholz, L. J., Weisberg, R. B., & Funderburk, J. S. (2018) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2017.12.004 · Cited by 44
Chen, J., Nakano, Y., Ietzugu, T., Ogawa, S., Funayama, T., Watanabe, N., Noda, Y., & Furukawa, T. A. (2007) · BMC Psychiatry · doi:10.1186/1471-244x-7-69 · Cited by 42
Psychological treatment of anxiety in primary care: a meta-analysis
Seekles, W., Cuijpers, P., Kok, R., Beekman, A., van Marwijk, H., & van Straten, A. (2013) · Psychological Medicine · doi:10.1017/s0033291712000670 · Cited by 41
Tolin, D. F. (2017) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2017.08.007 · Cited by 25
Bernik, M., Corregiari, F., Savoia, M. G., Barros Neto, T. P. D., Pinheiro, C., & Neto, F. L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205809 · Cited by 16
Mechanisms of Action in the Treatment of Social Anxiety Disorder
Otto, M. W., Safren, S. A., & Hearon, B. A. (2014) · Social Anxiety · doi:10.1016/b978-0-12-394427-6.00027-3 · Cited by 5
A Comparison between Psychosocial and Pharmacological Treatments
Powers, M. B., Kauffman, B. Y., Diamond, A., & Smits, J. A. J. (2014) · Social Anxiety · doi:10.1016/b978-0-12-394427-6.00026-1 · Cited by 3
Psychopharmacology for Social Anxiety Disorder
Blanco, C., Bragdon, L., Schneier, F. R., & Liebowitz, M. R. (2014) · Social Anxiety · doi:10.1016/b978-0-12-394427-6.00022-4 · Cited by 2
Metadata
- Authors
- Blomhoff, S., Haug, T. T., Hellström, K., Holme, I., Humble, M., Madsbu, H. P., & Wold, J. E.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2001-07
- Volume
- 179
- Issue
- 1
- Pages
- 23-30
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W1970766793
- Cited by
- 218
- References
- 7
- FWCI
- 16.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.